Brief: Xbrane Biopharma Q2 EBITDA Loss Widens To SEK 51.6 Mln
21/08/2020 07:19
Aug 21 (Reuters) - Xbrane Biopharma AB XBRANE.ST :
* Q2 EBITDA WAS SEK -51.6 M (-45.1*)
* Q2 THE LOSS FOR THE PERIOD WAS SEK 53.4 M (-47.4*).
* Q2 REVENUE AMOUNTED TO SEK 0 M (0).
Source text: urn:newsml:reuters.com:*:nMFN5gsgw
Further company coverage: XBRANE.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))